Health Condition 1: C692- Malignant neoplasm of retina
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.TUMOR HEIGHT >6MM 2.TUMORS INVOLVING FOVEA 3.ANY MEDIA HAZE PRECLUDING THE VISIBILITY OF TUMOR LIKE VITREOUS HAEMORRHAGE/ VITREOUS SEEDS 4.LARGELY CALCIFIED TUMORS 5.NOT WILLING TO GIVE ONSENT
Exclusion criteria
Exclusion criteria: 1.TUMOR HEIGHT >6MM 2.TUMORS INVOLVING FOVEA 3.ANY MEDIA HAZE PRECLUDING THE VISIBILITY OF TUMOR LIKE VITREOUS HAEMORRHAGE/ VITREOUS SEEDS 4.LARGELY CALCIFIED TUMORS 5.NOT WILLING TO GIVE ONSENT
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate if ICG enhanced TTT achieves greater reduction in Tumor height as compared to TTT alone in thick Retinoblastoma.Timepoint: Outcome will be assessed at baseline, 3weeks, 6weeks, 9weeks,12weeks under EUA OR till tumor height of less than 2mm, whichever is achieved earlier. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the complication rate between 2 groups.Timepoint: Outcome will be assessed at baseline, 3weeks, 6weeks, 9weeks,12weeks under EUA OR till tumor height of less than 2mm, whichever is achieved earlier. | — |
Countries
India
Contacts
Dr Rajendra Prasad Centre for Ophthalmic Sciences